165 filings
6-K
CLYYF
Celyad Oncology SA
17 Jan 24
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
6:33am
6-K
CLYYF
Celyad Oncology SA
21 Dec 23
Publication of a transparency notification received from Fortress Investment Group LLC
6:19am
6-K
CLYYF
Celyad Oncology SA
18 Dec 23
Current report (foreign)
12:29pm
6-K
CLYYF
Celyad Oncology SA
4 Dec 23
Celyad announces management change
1:28pm
6-K
CLYYF
Celyad Oncology SA
4 Dec 23
Current report (foreign)
1:26pm
6-K
8hfvxem a1rtu
24 Nov 23
Celyad Oncology reports third quarter 2023 financial
8:54am
6-K
oyt miy9mt
21 Nov 23
Publication of a transparency notification received from
4:05pm
6-K
ypk uoc35
21 Nov 23
Current report (foreign)
8:06am
6-K
vpa h8krb
15 Nov 23
Information on the Total Number of Voting Rights and Total Number of shares with single voting rights
4:37pm
6-K
9m7 ow9edbgdhm5ddn
27 Oct 23
Current report (foreign)
1:45pm
6-K
ltx4a
26 Sep 23
Celyad Oncology Announces the Termination of Its American Depository
6:06am
6-K
nb77 8yxc6ayoluivr
22 Sep 23
Current report (foreign)
6:06am
6-K
tmg0zrq94 zoj
18 Sep 23
Publication of a rectified transparency notification received from
6:04am
6-K
rmaj3den l1g1xh81
13 Sep 23
Current report (foreign)
6:29am
6-K
r2sr 0l3i4s3
11 Sep 23
Publication of a transparency notification received
6:21am
6-K
9gzcs5vpa
6 Sep 23
Current report (foreign)
6:04am
6-K
c29kbf
5 Sep 23
Celyad Oncology Reports First Half 2023 Financial
6:12am
6-K
wroxd jf4wycnnn
25 Aug 23
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
6:07am
6-K
tdr8pud7k1lfe
15 May 23
Celyad Oncology announces receipt of Nasdaq delisting notice
7:21pm
6-K
clu yp697
5 May 23
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
7:22am